Literature DB >> 24163708

Surgical therapeutic options.

Servet Bölükbas, Joachim Schirren.   

Abstract

Mesh:

Year:  2013        PMID: 24163708      PMCID: PMC3804758          DOI: 10.3238/arztebl.2013.0660a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.

Authors:  Servet Bölükbas; Christian Manegold; Michael Eberlein; Thomas Bergmann; Annette Fisseler-Eckhoff; Joachim Schirren
Journal:  Lung Cancer       Date:  2009-09-17       Impact factor: 5.705

2.  Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group.

Authors:  David Rice; Valerie Rusch; Harvey Pass; Hisao Asamura; Takashi Nakano; John Edwards; Dorothy J Giroux; Seiki Hasegawa; Kemp H Kernstine; David Waller; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2011-08       Impact factor: 15.609

Review 3.  [Malignant pleural mesothelioma: comparison of radical pleurectomy und extrapleural pneumonectomy].

Authors:  S Bölükbas; J Schirren
Journal:  Chirurg       Date:  2013-06       Impact factor: 0.955

Review 4.  Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.

Authors:  Volker Neumann; Stefan Löseke; Dennis Nowak; Felix J F Herth; Andrea Tannapfel
Journal:  Dtsch Arztebl Int       Date:  2013-05-03       Impact factor: 5.594

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.